References
Legrand M, Michel T, Daudon M, Benyamina M, Ferry A, Soussi S, Maurel V, Chaussard M, Chaouat M, Mimoun M, Verine J, Mallet V, Mebazaa A, PRONOBURN Study Group (2016) Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients. Intensive Care Med. doi:10.1007/s00134-016-4252-4
CYANOKIT® Hydroxocobalamin. Product monograph. http://www.medical-information.ca/wp-content/uploads/2015/07/CYANOKIT-HCP.pdf. Accessed 4 April 2016
Thompson JP, Marrs TC (2012) Hydroxocobalamin in cyanide poisoning. Clin Toxicol (Phila) 50:875–885
Borron SW, Stonerook M, Reid F (2006) Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol (Phila) 44(Suppl 1):5–15
Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C (2007) Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 49:794–801
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The author declares no conflict of interest.
Funding
None.
Rights and permissions
About this article
Cite this article
Mégarbane, B. Hydroxocobalamin-attributed risk of oxalate nephropathy: evidence is not sufficient to change the recommended management of cyanide toxicity by fire smoke inhalation. Intensive Care Med 42, 1197–1198 (2016). https://doi.org/10.1007/s00134-016-4354-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-016-4354-z